RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Robert Sambursky, MD
Rapid Pathogen Screening, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Manatee Sarasota Eye Clinic
Bradenton, Florida, United States
- Center for Excellence in Eye Care
Miami, Florida, United States
- St. John'S Clinics
Springfield, Missouri, United States
- Ophthalmic Consultants of Long Island
Lynbrook, New York, United States
- Physician Eyecare of Ny
New York, New York, United States
- Weill-Cornell Medical College
New York, New York, United States
- Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
- William F. Davitt, Iii, Md
El Paso, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2010
- Primary completion
- 31 Oct 2011
- Completion
- 31 Oct 2011
- Last update posted
- 12 Dec 2022
- Registered enrollment
- 206
- Registry id
- NCT01313351
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.